HL60 Antigen Antibodies

Santa Cruz Biotechnology features a diverse variety of HL60 Antigen monoclonal antibodies for advanced research in hematopoietic cell biology. HL60 Antigen monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The HL60 antigen is associated with the HL60 cell line, which is derived from human promyelocytic leukemia. The HL60 cell line serves as a model for studying myeloid differentiation and leukemia, making HL60 Antigen essential for understanding the mechanisms of hematopoiesis and the pathogenesis of blood cancers. Research focusing on HL60 Antigen can reveal important therapeutic targets and potential interventions in hematological malignancies. Understanding the role of HL60 Antigen in cellular processes has led to significant discoveries in cancer research. Investigating HL60 Antigen expression patterns helps researchers track disease progression and treatment effectiveness. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cancer biology and developing innovative treatment approaches.